文献速递产科母胎医学

产前住院孕妇焦虑、抑郁和压力的干预治疗:系统综述与Meta分析

Treatment for anxiety, depression, and stress in pregnant people experiencing antepartum hospitalization: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2025-01-23

该系统综述与Meta分析检索Ovid MEDLINE、Embase、CINAHL Plus、Cochrane CENTRAL和PsycINFO自建库至2023年4月,纳入3项随机对照研究(干预组226例,常规治疗组263例),发现干预可显著降低产前住院孕妇的焦虑(SMD -0.65,95%CI -0.83至-0.46)、抑郁(WMD -0.52,95%CI -0.76至-0.28)和压力(WMD -0.57,95%CI -0.82至-0.31)评分,但数据有限,需进一步高质量试验。

要点

  • 产前住院孕妇接受干预后焦虑评分较常规治疗显著降低,SMD -0.65(95%CI -0.83至-0.46)。
  • 抑郁评分较常规治疗显著降低,WMD -0.52(95%CI -0.76至-0.28)。
  • 压力评分较常规治疗显著降低,WMD -0.57(95%CI -0.82至-0.31)。

核心结论

  • 数据有限,但针对产前住院分娩者的干预可适度且显著降低焦虑、抑郁和压力症状。
  • 这些数据凸显需要进一步高质量试验以支持该高风险人群的心理健康需求。

研究设计与样本

  • 系统综述与Meta分析,检索Ovid MEDLINE、Embase、CINAHL Plus、Cochrane CENTRAL和PsycINFO自建库至2023年4月。
  • 纳入标准为随机对照试验和队列研究,比较干预与常规治疗(TAU)对产前住院孕妇焦虑、抑郁或压力症状的影响。
  • 两位作者独立筛选摘要并审阅可能符合纳入标准的全文。
  • 最终纳入3项研究(均为随机对照研究),干预组226例,常规治疗组263例。
  • 主要结局为干预后焦虑、抑郁或压力症状评估量表评分,采用Hedges法计算标准化均数差(SMD),同一量表研究采用加权均数差(WMD)。

主要发现

  • 共识别1185篇文章,审阅19篇全文,最终纳入3项研究(均为随机对照研究),干预组226例,常规治疗组263例。
  • 与常规治疗相比,干预显著降低焦虑症状验证量表平均评分,SMD -0.65(95%CI -0.83至-0.46)。
  • 与常规治疗相比,干预显著降低抑郁症状验证量表平均评分,WMD -0.52(95%CI -0.76至-0.28)。
  • 与常规治疗相比,干预显著降低压力症状验证量表平均评分,WMD -0.57(95%CI -0.82至-0.31)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 数据有限。
  • 需要进一步高质量试验以支持该高风险人群的心理健康需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To systematically evaluate inpatient interventions to reduce symptoms of anxiety, depression, or stress in pregnant individuals during antepartum hospitalization. DATA SOURCES: Searches were conducted in Ovid MEDLINE, Embase, CINAHL Plus, Cochrane CENTRAL, and PsycINFO from database inception through April 2023. STUDY ELIGIBILITY CRITERIA: Randomized controlled trials and cohort studies were eligible for inclusion if an intervention was compared to treatment as usual (TAU) to reduce symptoms of anxiety, depression, or stress among pregnant individuals admitted to a hospital's antepartum unit. STUDY APPRAISAL AND SYNTHESIS METHODS: Two authors independently screened all abstracts for eligibility and reviewed all potentially eligible full-text articles for inclusion. The primary outcome was the score on the assessment for symptoms of anxiety, depression, or stress after the intervention. The Hedges method was used to detect standardized mean difference (SMD) in studies using different psychometric scales, and weighted mean differences (WMD) were used in studies using the same psychometric scales. Risk of bias was assessed using the Cochrane Handbook for Systematic Reviews of Interventions. RESULTS: Of 1185 articles originally identified, 19 full-text manuscripts were reviewed, and 3 studies (all randomized controlled studies)-corresponding to 226 patients randomized to an intervention and 263 patients randomized to TAU-were included. Compared to TAU, interventions significantly reduced mean scores on validated scales assessing symptoms of anxiety (SMD -0.65 [95% Confidence Interval (CI) -0.83, -0.46]), depression (WMD -0.52 [95% CI -0.76, -0.28]), and stress (WMD -0.57 [95% CI -0.82, -0.31]). CONCLUSION: Though data are limited, interventions given to birthing people who experience antepartum hospitalization modestly-but significantly-reduce symptoms of anxiety, depression, and stress. These data highlight a need for further high-quality trials to support the mental health needs of this high-risk population. FUNDING: This project was supported by the Department of Maternal Fetal Medicine at the Alpert School of Medicine of Brown University. AKL was supported by NICHD (K23HD103961). ESM was supported by NICHD (R01HD105499) and NINR (R01NR021126-01). LGW was supported by K23HD107296-01A1 and P20GM139767. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42023444189 El resumen está disponible en Español al final del artículo.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Soehl JR, Anthony K, Lewkowitz AK, et al. Treatment for anxiety, depression, and stress in pregnant people experiencing antepartum hospitalization: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2025. PMID: 39863010. doi:10.1016/j.ajogmf.2025.101613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。